The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Stuart Nancy since 2014.
This trader's CIK number is 1594774.
At the time of last reporting, Stuart Nancy was the Chief Operating Officer of Concert Pharmaceuticals, Inc.. (stock ticker symbol CNCE).
Also see all insider trading activities at Concert Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | CNCE | 0 | $0 | 22,141 | $181,573 | 0 | $0 |
| 2022 | CNCE | 0 | $0 | 8,943 | $27,861 | 0 | $0 |
| 2021 | CNCE | 0 | $0 | 6,049 | $44,278 | 0 | $0 |
| 2020 | CNCE | 0 | $0 | 10,295 | $116,693 | 21,238 | $80,492 |
| 2019 | CNCE | 0 | $0 | 0 | $0 | 34,512 | $152,197 |
| 2018 | CNCE | 0 | $0 | 31,418 | $561,580 | 48,882 | $223,879 |
| 2017 | CNCE | 0 | $0 | 0 | $0 | 6,313 | $21,674 |
| 2016 | CNCE | 0 | $0 | 0 | $0 | 7,100 | $8,022 |
| 2015 | CNCE | 0 | $0 | 69,646 | $1,260,459 | 95,846 | $69,303 |
| 2014 | CNCE | 0 | $0 | 0 | $0 | 10,000 | $5,699 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-15 | CNCE | Sale | 6,048 | 8.33 | 50,379 |
| 2023-01-30 | CNCE | Sale | 13,200 | 8.35 | 110,220 |
| 2023-01-06 | CNCE | Sale | 2,893 | 7.25 | 20,974 |
| 2022-02-14 | CNCE | Sale | 6,049 | 3.08 | 18,630 |
| 2022-01-05 | CNCE | Sale | 2,894 | 3.19 | 9,231 |
| 2021-02-16 | CNCE | Sale | 6,049 | 7.32 | 44,278 |
| 2020-06-22 | CNCE | Sale | 10,295 | 11.34 | 116,693 |
| 2020-06-22 | CNCE | Option Ex | 21,238 | 3.79 | 80,492 |
| 2019-12-04 | CNCE | Option Ex | 5,896 | 4.41 | 26,001 |
| 2019-02-06 | CNCE | Option Ex | 28,616 | 4.41 | 126,196 |
| 2018-07-09 | CNCE | Sale | 5,291 | 17.56 | 92,888 |
| 2018-07-10 | CNCE | Sale | 26,127 | 17.94 | 468,692 |
| 2018-01-25 | CNCE | Option Ex | 48,882 | 4.58 | 223,879 |
| 2017-11-14 | CNCE | Option Ex | 4,215 | 4.58 | 19,304 |
| 2017-03-08 | CNCE | Option Ex | 2,098 | 1.13 | 2,370 |
| 2016-12-06 | CNCE | Option Ex | 7,100 | 1.13 | 8,022 |
| 2015-11-11 | CNCE | Option Ex | 9,200 | 1.13 | 10,395 |
| 2015-11-02 | CNCE | Sale | 23,216 | 24.29 | 564,009 |
| 2015-11-02 | CNCE | Option Ex | 23,216 | .57 | 13,233 |
| 2015-09-14 | CNCE | Option Ex | 17,000 | 1.13 | 19,210 |
| 2015-03-11 | CNCE | Sale | 46,430 | 15.00 | 696,450 |
| 2015-03-11 | CNCE | Option Ex | 46,430 | .57 | 26,465 |
| 2014-05-29 | CNCE | Option Ex | 10,000 | .57 | 5,699 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stuart Nancy (Chief Operating Officer of Concert Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.